Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gabriele Rohde"'
Autor:
Christian Hesse, Gabriele Rohde, Natalie Herth, Helen Mani, Gertrud Stratmann, Stephan Schwers, Edelgard Lindhoff-Last, Elisabeth Perzborn
Publikováno v:
Thrombosis and Haemostasis. 108:191-198
SummaryRivaroxaban is a direct factor Xa inhibitor, which can be monitored by anti-factor Xa chromogenic assays. This ex vivo study evaluated different assays for accurate determination of rivaroxaban levels. Eighty plasma samples from patients recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c298877bf49b60839095db8fc5e7bea
https://doi.org/10.1160/th11-12-0832
https://doi.org/10.1160/th11-12-0832
Autor:
Katharina E. Hofer, Wolfgang Korte, Gabriele Rohde, Michael Baumann, Karin Hasler, Alessandro Ceschi, Thomas Lehmann, Hugo Kupferschmidt
Publikováno v:
Thrombosis and Haemostasis. 112:834-836
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec01c8db91f16f5abeaf3bbd240b96ea
https://doi.org/10.1160/th14-02-0138
https://doi.org/10.1160/th14-02-0138
Autor:
Theodore E. Spiro, Jean Luc Martinoli, Genevieve Contant, Elisabeth Perzborn, Gabriele Rohde, Meyer Michel Samama, Céline Guinet, Yves Gourmelin, Léna Le Flem
Publikováno v:
Thrombosis Journal
Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of which greatly decreases thrombin generation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbbb14c1e3b8e5f30bcbf7e92ab2ae69
https://pubmed.ncbi.nlm.nih.gov/23822763
https://pubmed.ncbi.nlm.nih.gov/23822763
Autor:
Christoph Siethoff, Henning Blume, Margarete Brudny-Klöppel, Gabriele Rohde, Sylvia Grebe, E. Brendel, Berthold Lausecker
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 42(3)
This is a summary report of the workshop on the EMA Draft Guideline on Validation of Bioanalytical Methods held April 15-16th 2010 in Brussels (Belgium) and jointly organised by the European Bioanalysis Forum (EBF) and the European Federation for Pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296444d49d396c77bd6785eaeded39d4
https://pubmed.ncbi.nlm.nih.gov/21185936
https://pubmed.ncbi.nlm.nih.gov/21185936
Publikováno v:
Symposium (International) on Combustion. 24:661-668
The formation of the 1-hydroxyethyl radical and the reactions with oxygen and hydrogen atoms have been studied at low temperature (295 K) and low pressure (around 1 mbar) using isothermal discharge flow reactors, molecular beam sampling and mass spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c892ba9ec03586537aa9ccf86bd99143
https://doi.org/10.1016/s0082-0784(06)80081-0
https://doi.org/10.1016/s0082-0784(06)80081-0
Autor:
M.M. Samama, Gabriele Rohde, Theodore E. Spiro, Yves Gourmelin, Genevieve Contant, Jean-Luc Martinoli, Elisabeth Perzborn, Céline Guinet, L. Le Flem
Publikováno v:
European Journal of Hospital Pharmacy. 19:236.3-237
Background Rivaroxaban is an oral, direct Factor Xa inhibitor approved for clinical use for the prevention and treatment of thromboembolic disorders across several indications. Routine coagulation monitoring is not required, but a quantitative determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fdecb5f9a25f4c43dcddb7ae6400ecb
https://doi.org/10.1136/ejhpharm-2012-000074.398
https://doi.org/10.1136/ejhpharm-2012-000074.398